BAIV - ETF AI Analysis
Top Page
Brown Advisory International Value Select ETF (BAIV)
Rating:57Neutral
Price Target:―
Positive Factors
Recent Performance Momentum
The ETF has shown strong short-term gains over the last one and three months, suggesting positive recent momentum.
Global Diversification
Holdings spread across several major markets like the UK, U.S., Europe, and Japan help reduce the impact of weakness in any single country.
Broad Sector Mix
Exposure to a range of sectors, including consumer, financial, health care, and others, helps spread risk across different parts of the economy.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees each year.
Mixed Top Holding Performance
Some of the largest positions, such as Icon and Sanofi, have shown weak year-to-date performance, which can drag on overall returns.
Small Asset Base
With a relatively modest amount of assets under management, the ETF may be less liquid and more sensitive to large investor inflows or outflows.
BAIV vs. SPDR S&P 500 ETF (SPY)
AUM108.46M
RegionGlobal Ex-U.S.
Expense Ratio0.60%
Beta0.86
IssuerBrown Advisory
Inception DateFeb 25, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,884
30 Day Avg. Volume25,611
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
28.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering53
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BAIV Summary
Brown Advisory International Value Select ETF (BAIV) is an actively managed fund that looks for attractively priced companies outside the United States, rather than tracking a set index. It invests across many countries such as the UK, Japan, France, and Germany, and owns well-known names like Sanofi and British American Tobacco. Investors might consider BAIV to add international diversification and potential long-term growth from undervalued stocks that may have been overlooked. However, because it focuses on a smaller number of non-U.S. companies, its price can move sharply and is also affected by foreign market and currency swings.
How much will it cost me?This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, with managers researching and selecting international value stocks rather than just tracking an index.
What would affect this ETF?This international value ETF could benefit if economies outside the U.S. strengthen, especially in consumer, financial, and health care companies like Sanofi and Barclays, and if value stocks come back into favor as investors look for cheaper opportunities. On the downside, weaker growth overseas, currency swings, tighter regulations on tobacco and health care, or poor performance in a few large holdings could hurt returns because the fund is concentrated and focused only on non-U.S. markets.
BAIV Top 10 Holdings
BAIV leans into a concentrated mix of international value names, with health care and consumer staples doing much of the heavy lifting. Icon has been rising lately and looks like one of the fund’s key engines, while DCC and Barclays are also climbing and giving the portfolio some welcome momentum. On the flip side, Brenntag and Sanofi have been more mixed, occasionally tapping the brakes on performance. With all holdings outside the U.S. and spread across Europe and other developed markets, this ETF is a distinctly ex‑U.S. value play rather than a global tech story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Icon | 4.94% | $5.30M | $11.18B | -4.46% | 68 Neutral | |
| Magnum Ice Cream Co. N.V. | 3.98% | $4.27M | €8.73B | ― | ― | |
| Brenntag AG | 3.13% | $3.35M | €7.78B | -4.80% | 64 Neutral | |
| EDENRED | 2.77% | $2.97M | €5.65B | -3.87% | 62 Neutral | |
| Sanofi | 2.65% | $2.84M | $102.56B | -13.28% | 75 Outperform | |
| British American Tobacco | 2.58% | $2.77M | $123.89B | 20.80% | 59 Neutral | |
| ― | 2.41% | $2.59M | ― | ― | ― | |
| Fresenius Medical Care AG & Co. KGaA | 2.34% | $2.50M | €10.81B | -11.97% | 64 Neutral | |
| DCC plc | 2.31% | $2.47M | £5.30B | 35.02% | 71 Outperform | |
| Barclays | 2.26% | $2.42M | £67.06B | 61.93% | 78 Outperform |
BAIV Technical Analysis
Negative
―
Price Trends
25.19
Positive
Market Momentum
0.13
Positive
49.14
Neutral
20.00
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BAIV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 25.55, equal to the 50-day MA of 25.19, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 49.14 is Neutral, neither overbought nor oversold. The STOCH value of 20.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BAIV.
BAIV Peer Comparison
Comparison Results
Performance Comparison
BAIV
Brown Advisory International Value Select ETF
25.40
-0.02
-0.08%
JDVI
John Hancock Disciplined Value International Select ETF
―
―
―
OSEA
Harbor International Compounders ETF
―
―
―
BRIE
MFS Blended Research International Equity ETF
―
―
―
QLTI
GMO International Quality ETF
―
―
―
IDYN
iShares International Equity Factor Rotation Active ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents